Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
Objective To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex.Design and participants Cohort study of all German HCPs who voluntarily agreed that at least one payment they...
Main Authors: | Marlene Stoll, Lara Hubenschmid, Cora Koch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e037395.full |
Similar Items
-
Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
by: Marlene Stoll, et al.
Published: (2022-06-01) -
Voluntary disclosure of listed companies in Singapore.
by: Chang, Mun Ling., et al.
Published: (2008) -
Voluntary information disclosure in company annual reports
by: C. Firer, et al.
Published: (1985-12-01) -
Financial reporting quality and voluntary disclosures in private companies
by: Abdul-Jalil, A., et al.
Published: (2015) -
Voluntary disclosure by Shariah approved companies: an exploratory study
by: Ousama, Abdulrahman Anam, et al.
Published: (2010)